David D. Davey

Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry

Kirk McMillan, Marc Adler, Douglas S. Auld et al. · Proceedings of the National Academy of Sciences · 2000 · 200 citations · Full text

Preparation, Characterization, and the Crystal Structure of the Inhibitor ZK-807834 (CI-1031) Complexed with Factor Xa^,

Marc Adler, David D. Davey, Gary B. Phillips et al. · Biochemistry · 2000 · 110 citations · Full text

Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors

David D. Davey, Marc Adler, Damian O. Arnaiz et al. · Journal of Medicinal Chemistry · 2007 · 67 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Biochemistry +14

Discovery of <i>N</i>-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro- 6-[3-(4,5-dihydro-1-methyl-1<i>H</i>-imidazol-2-yl)phenoxy]pyridin-4-yl]-<i>N</i>-methylglycine (ZK-807834):  A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor Xa

Gary B. Phillips, Brad O. Buckman, David D. Davey et al. · Journal of Medicinal Chemistry · 1998 · 63 citations · Full text

Pharmaceutical Science, Altmetric Attention Score, Pharmacotherapy +16

Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogs

David D. Davey, Paul Erhardt, Elinor H. Cantor et al. · Journal of Medicinal Chemistry · 1991 · 44 citations